Table 1.
Topics and Panelists/Discussants During Phase 1
| Topic | Moderators and Panelists/Discussants | Location |
|---|---|---|
| GFR: history and evolution of kidney function measurement over the past 50 years | Neil Powe, MD, MPH, MBA; Cynthia Delgado, MD | |
| Andrew S. Levey, MD | Boston, Massachusetts | |
| GFR: measurement, estimation, performance in the United States | Lesley Inker, MD | |
| Josef Coresh, MD, MPH | Baltimore, Maryland | |
| Susan L. Furth, MD, PhD | Philadelphia, Pennsylvania | |
| Andrew S. Levey, MD | Boston, Massachusetts | |
| Julia B. Lewis, MD | Nashville, Tennessee | |
| Robert G. Nelson, MD, PhD | Bethesda, Maryland | |
| Derek K. Ng, PhD | Baltimore, Maryland | |
| Andrew D. Rule, MD | Rochester, Minnesota | |
| George Schwartz, MD | Rochester, New York | |
| Race and racism; genetic ancestry and race; creatinine, race and ancestry | Deidra Crews, MD, ScM | |
| Camara Phyllis Jones, MD, PhDa | Atlanta, Georgia | |
| David R. Williams, PhDa | Boston, Massachusetts | |
| Dorothy E. Roberts, JDa | Philadelphia, Pennsylvania | |
| Nora Franceschini, MD | Chapel Hill, North Carolina | |
| Alicia R. Martin, PhD | Boston, Massachusetts | |
| Miriam S. Udler, MD, PhD | Baston, Massachusetts | |
| Esteban G. Burchard, MD | San Francisco, California | |
| Jeffery B. Kopp, MD | Bethesda, Maryland | |
| Opeyemi A. Olabisi, MD, PhD | Durham, North Carolina | |
| Body composition and populations used in eGFR estimation | Cynthia Delgado, MD | |
| Kamyar Kalantar-Zadeh, MD, PhD | Los Angeles, California | |
| Andrew D. Rule, MD | Rochester, Minnesota | |
| Glenn M. Chertow, MD | Palo Alto, California | |
| Kirsten L. Johansen, MD | Minneapolis, Minnesota | |
| Baback Roshanravan, MD | Davis, California | |
| Flor Alvorado, MD | Baltimore Maryland | |
| Abinet M. Aklilu, MD | New Haven, Connecticut | |
| Laboratory standardization issues with markers and guidelines | Greg Miller, PhD; Mukta Baweja, MD | |
| Adeera Levin, MD, FRCPC | Vancouver, British Columbia | |
| Amy D. Karger, MD, PhD | Minneapolis, Minnesota | |
| Andrew S. Narva, MD | Washington, DC | |
| Harvey Kaufman, MD, FCAP, MBA | Short Hills, New Jersey | |
| Holly J. Kramer, MD, MPH | Maywood, Illinois | |
| James Fleming, PhD, FACB | Greensboro, North Carolina | |
| Joseph A. Vassalotti, MD | New York, New York | |
| Neil Greenberg, PhD, DABCC | Cleveland, Ohio | |
| Ravi I. Thadhani, MD, MPH | Boston, Massachusetts | |
| Wolfgang C. Winkelmayer, MD, ScD | Houston, Texas | |
| W. Greg Miller, PhD | Richmond, Virginia | |
| Patient perspective and participatory decision-making experience and patient-centered considerations | Glenda Roberts, BSc; Curtis Warfield, MS | |
| Monica Peek, MD, MPH | Chicago, Illinois | |
| David White | Brooklyn, New York | |
| Richard Knight | Bowie, Maryland | |
| Keren Ladin, PhD, MSc | Medford, Massachusetts | |
| Kevin Fowler, BA | Chicago, Illinois | |
| Rajnish Mehrotra, MD | Seattle, Washington | |
| Allison Tong, PhD, MPHb | Sydney, Australia | |
| L. Ebony Boulware, MD | Durham, North Carolina | |
| H. Gilbert Welch, MD | Boston, Massachusetts | |
| Possible approaches to address race in GFR estimation | Neil Powe, MD, MPH, MBA; Cynthia Delgado, MD | |
| Task Force Members | ||
Previously disseminated video talks were reviewed for these individuals due to their availability.
Video talk was reviewed for this individual due to their availability.